Hairy and enhancer of split 1 (HES1) (HES1)

Hairy and enhancer of split 1 (HES1) is a basic helix-loop-helix (bHLH) transcription factor that primarily functions as a transcriptional repressor [1, 6]. It is the principal downstream mediator of the Notch signaling pathway, though its expression can also be regulated by other oncogenic pathways such as Wnt, Hedgehog, and TGF-beta [1, 5]. HES1 plays a critical role during embryonic development by controlling cell fate decisions, neurogenesis, and organogenesis, and it remains essential in adult tissues for maintaining the self-renewal capacity of stem and progenitor cells [2, 14]. In various human malignancies, HES1 is frequently overexpressed, which promotes tumor growth, epithelial-mesenchymal transition (EMT), and the maintenance of cancer stem cells [5, 13]. Because of its central role in driving aggressive tumor phenotypes and therapy resistance, it is considered a high-value therapeutic target [4, 13]. Current clinical strategies largely focus on indirect targeting via gamma-secretase inhibitors to block Notch signaling, but emerging research is exploring direct small-molecule inhibitors to bypass the broad toxicities associated with Notch inhibition [11, 12]. However, therapeutic intervention remains challenging due to the protein's essential functions in maintaining normal gut and immune system homeostasis [10, 14].

Other names

Transcription factor HES-1Class B basic helix-loop-helix protein 39bHLHb39Hairy homologHairy-like proteinHHLHRY

Indirect inhibition of HES1 expression via gamma-secretase inhibitors (GSIs) that block Notch pathway activation; direct disruption of HES1 DNA-binding or transcriptional repression activity is currently under research investigation.